Lovastatin and Colcrys drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lovastatin (lovastatin) and Colcrys (colchicine). Common drug interactions include drug ineffective among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Lovastatin and Colcrys. It is created by eHealthMe based on reports of 86 people who take the same drugs from the FDA, and is updated regularly.

What is Lovastatin?

Lovastatin has active ingredients of lovastatin. It is often used in high blood cholesterol. eHealthMe is studying from 33,048 Lovastatin users. Check the latest studies of Lovastatin.

What is Colcrys?

Colcrys has active ingredients of colchicine. It is often used in gout. eHealthMe is studying from 4,546 Colcrys users. Check the latest studies of Colcrys.



On Jul, 28, 2026

86 people who take Lovastatin and Colcrys together, and have interactions are studied.

Lovastatin and Colcrys drug interactions.

What are the common drug interactions of Lovastatin and Colcrys, by gender? *:

female:

  1. Drug ineffective
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Haemoglobin decreased
  4. Oedema peripheral (superficial swelling)
  5. Pneumonia
  6. Pruritus (severe itching of the skin)
  7. Chest pain
  8. Drug hypersensitivity
  9. Arrhythmia (irregular heartbeat)
  10. Arthralgia (joint pain)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Death
  4. Decreased appetite
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Nausea (feeling of having an urge to vomit)
  8. Platelet count increased
  9. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  10. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the common drug interactions of Lovastatin and Colcrys, by age (0-1 to 60+)? *:

0-1:

  1. Chest discomfort

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Renal injury (kidney injury)
  4. Depression
  5. Suicidal ideation

40-49:

  1. Anxiety
  2. Arthralgia (joint pain)
  3. Compulsive sexual behaviour (unable to manage his/her sexual behaviour)
  4. Compulsive shopping
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Cough
  7. Decreased appetite
  8. Dyspnoea (difficult or laboured respiration)
  9. Eating disorder
  10. Fatigue (feeling of tiredness)

50-59:

  1. Renal injury (kidney injury)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Chronic kidney disease
  4. Renal failure (kidney dysfunction)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Abscess (pus)
  7. Abscess neck (neck abscesses)
  8. Anal abscess
  9. Arrhythmia (irregular heartbeat)
  10. Cellulitis (infection under the skin)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Pain in extremity
  4. Peripheral swelling
  5. Skin exfoliation (removal of the oldest dead skin cells)
  6. Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
  7. Blood potassium increased
  8. Cellulitis (infection under the skin)
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the existing conditions these people have? *

  1. High Blood Pressure: 20 people, 23.26%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 19 people, 22.09%
  3. Diabetes: 13 people, 15.12%
  4. Fluid Retention (an abnormal accumulation of fluid in the blood): 10 people, 11.63%
  5. Pain: 9 people, 10.47%
  6. Multiple Myeloma (cancer of the plasma cells): 9 people, 10.47%
  7. Infection: 9 people, 10.47%
  8. Blood Pressure Abnormal: 7 people, 8.14%
  9. Chest Pain: 7 people, 8.14%
  10. Essential Hypertension (primary hypertension): 6 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Lovastatin and Colcrys?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lovastatin and Colcrys:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lovastatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Colcrys:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lovastatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Colcrys and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lovastatin and colchicine (the active ingredients of Lovastatin and Colcrys, respectively), and Lovastatin and Colcrys (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: